Background And Aims: Patients with chronic pancreatitis (CP) may develop pancreatic exocrine insufficiency (PEI) but data regarding subclinical PEI are scarce. Our objective was to detect subclinical PEI in patients with CP and its functional consequences.
Methods: We prospectively included patients with CP from April 2018-December 2021.
Clin Gastroenterol Hepatol
October 2020
Tissue transglutaminse-2 (TG2)-based immunoassays are the cornerstone of diagnosis in celiac disease (CeD), with a reported pooled sensitivity as high as 98%. However, a few small, single-center studies have questioned their sensitivity in clinical practice. Moreover, commercial kits use variable TG2 antigens, with cutoffs determined by using small, poorly defined populations.
View Article and Find Full Text PDF